AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (253.5 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Perspective | Open Access

XPO1 as a key regulator in small cell lung cancer: mechanisms, biomarkers, and therapeutic implications

Tingting Qin1,2, Jingya Wang1,2, Dingzhi Huang1,2 ( )
Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
Tianjin’s Clinical Research Center for Cancer, Department of Thoracic Oncology, Tianjin Lung Cancer Center, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Tianjin 300060, China
Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Cancer Biology & Medicine
Volume 22 Issue 6,
June 2025
Pages 543-548
DOI: 10.20892/j.issn.2095-3941.2025.0215

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Qin T, Wang J, Huang D. XPO1 as a key regulator in small cell lung cancer: mechanisms, biomarkers, and therapeutic implications. Cancer Biology & Medicine, 2025, 22(6): 543-548. https://doi.org/10.20892/j.issn.2095-3941.2025.0215

420

Views

25

Downloads

0

Crossref

0

Web of Science

0

Scopus
Received: 22 April 2025
Accepted: 03 June 2025
Published: 27 June 2025
©2025 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License